limit tamoxifen use to 5 years

The National Cancer Institute is now alerting oncologists to limit tamoxifen use to 5 years...for certain women being treated for early-stage breast cancer.

Taking tamoxifen for 5 years after lumpectomy or mastectomy significantly reduces the risk of recurrence and improves survival.

New evidence says that LONGER use doesn't further improve survival. It might even be detrimental...by increasing uterine cancer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote